Discover open access scientific publications

Search, annotate, share and cite publications

Publications by E. V. Karabina

The Mechanisms of Acquired Resistance to Anti-Egfr Drugs in Non-Small Cell Lung Cancer Not Associated With T790m Mutation and Their Significance in Clinical Practice

Advances in molecular oncology
2018English

Efficacy and Safety of Lenvatinib in Combination With Everolimus in Metastatic Renal Cell Carcinoma Resistant to Antiangiogenic Targeted Therapy: Russian Multicenter Observational Study ROSLERCM

Onkourologiya
OncologyRadiologyUrologyNuclear MedicineNephrologyImagingSurgery
2019English

Related publications

Acquired EGFR C797S Mutation Mediates Resistance to AZD9291 in Non–small Cell Lung Cancer Harboring EGFR T790M

Nature Medicine
BiochemistryMedicineGeneticsMolecular Biology
2015English

Non-Invasive Urine Testing of EGFR Activating Mutation and T790M Resistance Mutation in Non-Small Cell Lung Cancer

Experimental Hematology and Oncology
Cancer ResearchOncologyHematology
2015English

Clinical Characteristics of Osimertinib Responder in Non-Small Cell Lung Cancer Patients With EGFR-T790M Mutation

Cancers
Cancer ResearchOncology
2019English

Assessment of Resistance Mechanisms and Clinical Implications in Patients With EGFR T790M–Positive Lung Cancer and Acquired Resistance to Osimertinib

JAMA Oncology
Cancer ResearchOncology
2018English

Molecular Mechanisms of Acquired Resistance to Third-Generation EGFR-TKIs in EGFR T790m-Mutant Lung Cancer

Annals of Oncology
MedicineOncologyHematology
2019English

P3.01-39 Analysis of Acquired EGFR T790M Mutation in Patients With Non-Small Cell Lung Cancer Who Received Icotinib Progress

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Primary Concomitant EGFR T790M Mutation Predicted Worse Prognosis in Non-Small Cell Lung Cancer Patients

OncoTargets and Therapy
OncologyPharmacology
2014English

Newly Emergent Acquired EGFR Exon 18 G724S Mutation After Resistance of a T790M Specific EGFR Inhibitor Osimertinib in Non-Small-Cell Lung Cancer: A Case Report

OncoTargets and Therapy
OncologyPharmacology
2018English

P2.13-22 Resistant Patterns to Osimertinib in Non-Small Cell Lung Cancer Patients With Both T790M and Sensitizing EGFR Mutation

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy